"Our new Nanosonics CORIS platform technology, like trophon,...

"Our new Nanosonics CORIS platform technology, like trophon, will comprise both capital equipment and consumables. In testing to date, this new automated technology has demonstrated the ability to deliver significant superiority in cleaning efficacy over the requirements of the current standards including the most recent standards that are even stricter. In addition, testing demonstrates superior efficacy over manual cleaning against difficult biofilm contamination, including in the smallest channels of an endoscope.

We are very pleased with our progress in the product’s development. There is some more development work to do which will be followed by external clinical assessment to support the regulatory submissions and we are currently targeting the first commercial launch in calendar 2023." (Nanosonics AGM transcript).

Looks like they are in the testing phase and following a successful clinical trial will launch in 2023. Assumes a FDA approval in 2022.